Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines

PaperCitations, authors & open-access status

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 89 citations, 2017 year and gold oa status.

89
Citations
2017
Year
gold
OA Status

Related on ScholarIQ

Silvia La Monica
Author
Journal of Experimental & Clinical Cancer Research
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
HER2/EGFR in Cancer Research
Topic
Colorectal Cancer Treatments and Studies
Topic
470M+ articles · free account